Lupus News

European researchers recently published recommendations for child-onset lupus, as well as neuropsychiatric child-onset lupus.

In patients with lupus, ongoing use of hydroxychloroquine plus low-dose aspirin may be associated with increased effectiveness in the primary prevention of cardiovascular events, according to recently published findings.

Among patients with lupus, B-cell monitoring can guide treatment with anti-CD-20 agents, according to a recently published study.

Statins had no effect on lupus risk among middle-aged patients, according to a recently published study.

In a population of patients with lupus, the ubiquitin ligase modulator CC-220 appeared to be generally well-tolerated, with neutropenia and dermatitis seen at the highest doses assessed, according to a study presented at the EULAR Annual Congress.

Healio Rheumatology recently interviewed Richard Furie, MD, from Hofstra Northwell School of Medicine, Lars Rönnblom, MD, from Uppsala University in Sweden, and Peggy K. Crow, MD, from Hospital for Special Surgery, about the future of lupus during the Interferon Summit.

MADRID — Belimumab plus standard therapy was safe and effective over 10 years in patients with lupus, according to findings presented at the EULAR Annual Congress.

The American College of Rheumatology has partnered with the American Association of Hip and Knee Surgeons to develop evidence-based guidelines for perioperative management of antirheumatic medication for patients with rheumatic diseases who undergo total joint replacement.

The American College of Rheumatology has partnered with the American Association of Hip and Knee Surgeons to develop evidence-based guidelines for perioperative management of antirheumatic medication for patients with rheumatic diseases who undergo total joint replacement.

MADRID — Long-term use of hydroxychloroquine was associated with reduced cardiovascular risks in a cohort of patients with systemic lupus erythematosus, according to findings presented at the EULAR Annual Congress.